Shant Apelian//LinkedIn
Apr 29, 2026, 10:19
Shant Apelian: Impact of Caffeine on Neurodevelopmental Outcomes in Preterm Infants
Shant Apelian, Postdoctoral Researcher in Obstetrics and Gynecology at Yale University, shared a post on LinkedIn about a paper shared in Pediatrics and Neonatology:
“Thrilled to share our new publication in Pediatrics and Neonatology
‘Impact of caffeine on neurodevelopmental outcomes in preterm infants: A systematic review and meta-analysis’
We found that caffeine, as a medication in preterm infants, might improves motor and cognitive outcomes and reduces the risk of cerebral palsy, with no significant effect on language development.
Always happy to learn and grow in the research field!”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 13, 2026, 16:24Shanza Ghaffar: Recurrent Pregnancy Loss Beyond Diagnosis and Treatment
-
May 13, 2026, 16:16Alejandro González: A Historic Moment for the PCOS Community
-
May 13, 2026, 16:15Antonio La Marca: Where There Is Research, There Is Better Care
-
May 13, 2026, 16:06Mirjam Teboe: APS Diagnosis Faces False Positive Challenges in Lupus Anticoagulant Testing
-
May 13, 2026, 16:03The Link Between Lifestyle and Environmental Exposures and Endometriotic Phenotype – RBMO
-
May 13, 2026, 11:42Analysis of MED-12 Mutations in Uterine Leiomyomas of Nigerian Women – Fertility and Sterility
-
May 13, 2026, 11:33Anuja Dokras: SPIRE 2026 Brings Together the Global Fertility Community
-
May 13, 2026, 11:23Sean Lauber: Why Do Aneuploid Embryos Rarely Lead to Live Births?
-
May 13, 2026, 10:40Polyendocrine Metabolic Ovarian Syndrome, the New Name for PCOS – PCOS Awareness Association